Publications by authors named "Lena Lenhammar"

Claim this Profile
I
Immuno-oncological effects of standard anticancer agents and commonly used concomitant drugs: an in vitro assessment.
Tove Selvin, Malin Berglund, Lena Lenhammar, Magnus Lindskog, Malin Jarvius

BMC Pharmacol Toxicol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic screening platform identifies statins as enhancers of immune cell-induced cancer cell death.
Tove Selvin, Malin Berglund, Lena Lenhammar, Malin Jarvius, Peter Nygren

BMC Cancer· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against and .
Andrej Emanuel Cotman, Martina Durcik, Davide Benedetto Tiz, Federica Fulgheri, Daniela Secci, Lena Lenhammar

J Med Chem· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mebendazole is unique among tubulin-active drugs in activating the MEK-ERK pathway.
Claes R Andersson, Tove Selvin, Kristin Blom, Jenny Rubin, Malin Berglund, Lena Lenhammar

Sci Rep· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mebendazole-induced M1 polarisation of THP-1 macrophages may involve DYRK1B inhibition.
Kristin Blom, Jenny Rubin, Malin Berglund, Malin Jarvius, Lena Lenhammar

BMC Res Notes· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mebendazole stimulates CD14+ myeloid cells to enhance T-cell activation and tumour cell killing.
Jenny Rubin, Sharmineh Mansoori, Kristin Blom, Malin Berglund, Lena Lenhammar

Oncotarget· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation.
Kristin Blom, Wojciech Senkowski, Malin Jarvius, Malin Berglund, Jenny Rubin, Lena Lenhammar

Immunopharmacol Immunotoxicol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design, synthesis and in vitro biological evaluation of oligopeptides targeting E. coli type I signal peptidase (LepB).
Maria De Rosa, Lu Lu, Edouard Zamaratski, Natalia Szałaj, Sha Cao, Lena Lenhammar

Bioorg Med Chem· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis